Quest Water Global (QWTR) 10-Q 10 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 10, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	333-168895
Entity Registrant Name	QUEST WATER GLOBAL, INC.
Entity Central Index Key	0001487091
Entity Tax Identification Number	27-1994359
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	Suite 209 – 828 Harbourside Drive
Entity Address, City or Town	North Vancouver
Entity Address, State or Province	BC
Entity Address, Country	CA
Entity Address, Postal Zip Code	V7P 3R9
City Area Code	888
Local Phone Number	897-5536
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		131,903,029

Condensed Consolidated Interim

Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 54	$ 4,227
Prepaids	4,453
Total current assets	4,507	4,227
Equipment, net (Note 4)	1,292
Investment (Note 3)	7,220	7,220
Total assets	13,019	11,447
Current liabilities
Accounts payable and accrued liabilities	27,843	15,100
Due to related company (Note 3)	12,606	33,964
Due to related parties (Note 5)	1,030,496	3,632,758
Total liabilities	1,070,945	3,681,822
Stockholders’ deficit
Preferred stock, 5,000,000 shares authorized, $0.000001 par value 2 shares issued and outstanding	1	1
Common stock, 500,000,000 shares authorized, $0.000001 par value 131,903,029 issued and outstanding	132	85
Additional paid-in capital	10,171,803	6,332,748
Deficit	(11,229,862)	(10,003,209)
Total stockholders’ deficit	(1,057,926)	(3,670,375)
Total liabilities and stockholders’ deficit	$ 13,019	$ 11,447

Condensed Consolidated Interi_2

Condensed Consolidated Interim Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value	$ 0.000001	$ 0.000001
Preferred stock, shares issued	2	2
Preferred stock, shares outstanding	2	2
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value	$ 0.000001	$ 0.000001
Common stock, shares issued	131,903,029	131,903,029
Common stock, shares outstanding	131,903,029	131,903,029

Condensed Consolidated Interi_3

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Sales		$ 790		$ 150,790
Cost of goods sold		1,050		113,774
Gross profit		(260)		37,016
Expenses
Automotive	2,417	2,307	7,732	7,111
Consulting fees		771		771
Management fees	112,500	107,500	337,500	322,500
Office and miscellaneous	5	(880)	3,256	3,342
Professional fees	12,921	8,884	40,078	9,271
Rent	5,470	5,250	16,259	15,750
Telephone	762	712	2,602	2,350
Transfer agent and filing fees	4,120	6,487	18,124	7,119
Stock based compensation	801,102		801,102
Total expenses	939,297	131,031	1,226,653	368,214
Net loss and comprehensive loss	$ (939,297)	$ (131,291)	$ (1,226,653)	$ (331,198)
Net loss per share, basic and diluted	$ (0.008)	$ (0.002)	$ (0.012)	$ (0.004)
Weighted average number of shares outstanding, basic and diluted	120,726,441	85,164,569	97,148,790	85,164,569

Condensed Consolidated Interi_4

Condensed Consolidated Interim Statements of Stockholder's Deficit (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 1	$ 85	$ 6,332,748	$ (9,741,165)	$ (3,408,331)
Beginning balance, shares at Dec. 31, 2020	2	85,164,569
Net loss for the period				(82,553)	(82,553)
Ending balance, value at Mar. 31, 2021	$ 1	$ 85	6,332,748	(9,823,718)	(3,490,884)
Ending balance, shares at Mar. 31, 2021	2	85,164,569
Beginning balance, value at Dec. 31, 2020	$ 1	$ 85	6,332,748	(9,741,165)	(3,408,331)
Beginning balance, shares at Dec. 31, 2020	2	85,164,569
Net loss for the period					(331,198)
Shares issued for debt
Stock based compensation
Ending balance, value at Sep. 30, 2021	$ 1	$ 85	6,332,748	(10,072,363)	(3,739,529)
Ending balance, shares at Sep. 30, 2021	2	85,164,569
Beginning balance, value at Mar. 31, 2021	$ 1	$ 85	6,332,748	(9,823,718)	(3,490,884)
Beginning balance, shares at Mar. 31, 2021	2	85,164,569
Net loss for the period				(117,354)	(117,354)
Ending balance, value at Jun. 30, 2021	$ 1	$ 85	6,332,748	(9,941,072)	(3,608,238)
Ending balance, shares at Jun. 30, 2021	2	85,164,569
Net loss for the period				(131,291)	(131,291)
Stock based compensation
Ending balance, value at Sep. 30, 2021	$ 1	$ 85	6,332,748	(10,072,363)	(3,739,529)
Ending balance, shares at Sep. 30, 2021	2	85,164,569
Beginning balance, value at Dec. 31, 2021	$ 1	$ 85	6,332,748	(10,003,209)	(3,670,375)
Beginning balance, shares at Dec. 31, 2021	2	85,164,569
Net loss for the period				(144,635)	(144,635)
Ending balance, value at Mar. 31, 2022	$ 1	$ 85	6,332,748	(10,147,844)	(3,815,010)
Ending balance, shares at Mar. 31, 2022	2	85,164,569
Beginning balance, value at Dec. 31, 2021	$ 1	$ 85	6,332,748	(10,003,209)	(3,670,375)
Beginning balance, shares at Dec. 31, 2021	2	85,164,569
Net loss for the period					(1,226,653)
Shares issued for debt					(3,038,000)
Stock based compensation					801,102
Ending balance, value at Sep. 30, 2022	$ 1	$ 132	10,171,803	(11,229,862)	(1,057,926)
Ending balance, shares at Sep. 30, 2022	2	131,903,029
Beginning balance, value at Mar. 31, 2022	$ 1	$ 85	6,332,748	(10,147,844)	(3,815,010)
Beginning balance, shares at Mar. 31, 2022	2	85,164,569
Net loss for the period				(142,721)	(142,721)
Ending balance, value at Jun. 30, 2022	$ 1	$ 85	6,332,748	(10,290,565)	(3,957,731)
Ending balance, shares at Jun. 30, 2022	2	85,164,569
Net loss for the period				(939,297)	(939,297)
Shares issued for debt		$ 47	3,037,953		3,038,000
Shares issued for debt, shares		43,738,460
Stock based compensation			801,102		801,102
Ending balance, value at Sep. 30, 2022	$ 1	$ 132	$ 10,171,803	$ (11,229,862)	$ (1,057,926)
Ending balance, shares at Sep. 30, 2022	2	131,903,029

Condensed Consolidated Interi_5

Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Operating Activities:
Net loss for the period	$ (939,297)	$ (1,226,653)	$ (331,198)
Depreciation		208
Shares issued for debt	(3,038,000)	3,038,000
Stock based compensation	801,102	801,102
Changes in operating assets and liabilities:
Prepaids		(4,453)	(7,541)
Unbilled costs			112,724
Accounts payable and accrued liabilities		12,743	(14,165)
Due to related company		(21,358)	(150,000)
Due to related parties		(2,602,262)	389,749
Net cash used in operating activities		(2,673)	(431)
Cash flows from investing activities:
Equipment purchases		(1,500)
Net cash used in investing activities		(1,500)
Change in cash		(4,173)	(431)
Cash, beginning of period		4,227	4,715
Cash, end of period	$ 54	54	4,284
Supplemental disclosures:
Interest paid
Income tax paid

Nature of Operations and Contin

Nature of Operations and Continuance of Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Continuance of Business	1. Nature of Operations and Continuance of Business Quest Water Global, Inc. (the “Company”) was incorporated on February 25, 2010, under the laws of the State of Delaware. The Company is an innovative water technology company that provides solutions to water scarce regions. The Company’s operations to date have been limited primarily to capital formation, organization, and development of its business plan. On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant, but management continues to monitor the situation. These consolidated interim financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at September 30, 2022, the Company has a working capital deficiency of $ 1,066,438 1,030,496 11,229,862

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies (a) Basis of Presentation and Principles of Consolidation These consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in US dollars. These consolidated financial statements include the accounts of the Company; the Company’s wholly-owned subsidiary Quest Water Solutions, Inc., a company incorporated under the laws of the State of Nevada (“Quest Nevada”); AQUAtap Global, Inc., a company incorporated under the laws of the State of Wyoming; and Quest Nevada’s wholly-owned subsidiary, Quest Water Solutions Inc., a company incorporated under the laws of the Province of British Columbia, Canada. All inter-company balances and transactions have been eliminated on consolidation. (b) Interim Financial Statements The accompanying condensed consolidated interim financial statements of the Company should be read in conjunction with the consolidated financial statements and accompanying notes for the fiscal year ended December 31, 2021. In the opinion of management, the accompanying condensed consolidated interim financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown. The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year. (c) Foreign Currency Translation The Company’s functional currency is US dollars. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into US dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in income. The Company’s integrated foreign subsidiaries are financially or operationally dependent on the Company. The Company uses the temporal method to translate the accounts of its integrated operations into US dollars. Monetary assets and liabilities are translated at the exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are translated at historical rates. Revenues and expenses are translated at average rates for the period, except for amortization, which is translated on the same basis as the related asset. The resulting exchange gains or losses are recognized in income. (d) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Investment in and Due to Relate

Investment in and Due to Related Company	9 Months Ended
	Sep. 30, 2022
Investments, All Other Investments [Abstract]
Investment in and Due to Related Company	3. Investment in and Due to Related Company During the year ended December 31, 2019, the Company invested $ 7,600 38 no As at December 31, 2020, AQUAtap had advanced $ 183,964 150,000 During the year ended December 31, 2021, the sale was completed and the Company recorded the prepayment as a sale. Accordingly, as at December 31, 2021, the account was reduced by $ 150,000 33,964

Equipment

Equipment	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Equipment	4. Equipment Equipment is amortized over its useful life. Schedule of Property and Equipment Cost Depreciation Net Computer 3 years $ 1,500 $ 208 $ 1,292

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	5. Related Party Transactions (a) As at September 30, 2022, a total of $ 431,638 1,703,755 (b) As at September 30, 2022, a total of $ 598,858 1,929,003 (c) For the nine months ended September 30, 2022, the Company incurred a total of $ 337,500 322,500 (d) For the nine months ended September 30, 2022, the Company incurred $ 15,750 15,750 (e) On July 22, 2022, the Company issued 46,738,460 0.065 3,038,000

Common Stock

Common Stock	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Common Stock	6. Common Stock On July 21, 2022, the authorized capital of the Company was increased from 95,000,000 500,000,000 0.000001 On July 22, 2022, the Company converted an aggregate of $ 3,038,000 46,738,460 0.065 At September 30, 2022, the Company had 131,903,029 85,164,569 Basic and diluted loss per share The calculation of the basic and diluted loss per share for the nine months ended September 30, 2022 was based on the loss attributable to common shareholders of $ 454,684 331,198 97,148,790 85,164,569 At September 30, 2022, 8,500,000

Share Based Payments

Share Based Payments	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share Based Payments	7. Share Based Payments Stock Options The Company adopted a stock option plan in May 2012 (the “Plan”) under which it is authorized to grant options to directors, officers, employees and consultants enabling them to acquire up to a maximum of 10 10 Stock option transactions are summarized as follows: Summary of Stock Option Activity Number of Weighted Average Options Exercise Price Balance, December 31, 2021 - $ - Granted 8,500,000 0.10 Exercised - - Cancelled/Expired - - Balance, September 30, 2022 8,500,000 $ 0.10 Exercisable at September 30, 2022 7,700,000 $ 0.10 The options outstanding and exercisable at September 30, 2022 have an exercise price of $ 0.10 4.79 800,000 0.10 For the nine months ended September 30, 2022, the Company recognized stock based payment expense of $ 801,102

Correction of Previously Issued

Correction of Previously Issued Financial Statements	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Correction of Previously Issued Financial Statements	8. Correction of Previously Issued Financial Statements During the year ended December 31, 2014, the Company entered into consulting and marketing agreements whereby it committed to issue 500,000 40,025 The following changes reflect the adjustment of $ 40,025 Consolidated Statement of Stockholders’ Deficit Schedule of Stockholders’ Deficit Common stock Deficit Total $ $ $ Balance, December 31, 2020, as previously stated 40,025 (9,781,190 ) (3,408,331 ) Adjustment (40,025 ) 40,025 – Balance, December 31, 2020, as restated – (9,741,165 ) (3,408,331 )

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	(a) Basis of Presentation and Principles of Consolidation These consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in US dollars. These consolidated financial statements include the accounts of the Company; the Company’s wholly-owned subsidiary Quest Water Solutions, Inc., a company incorporated under the laws of the State of Nevada (“Quest Nevada”); AQUAtap Global, Inc., a company incorporated under the laws of the State of Wyoming; and Quest Nevada’s wholly-owned subsidiary, Quest Water Solutions Inc., a company incorporated under the laws of the Province of British Columbia, Canada. All inter-company balances and transactions have been eliminated on consolidation.
Interim Financial Statements	(b) Interim Financial Statements The accompanying condensed consolidated interim financial statements of the Company should be read in conjunction with the consolidated financial statements and accompanying notes for the fiscal year ended December 31, 2021. In the opinion of management, the accompanying condensed consolidated interim financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown. The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year.
Foreign Currency Translation	(c) Foreign Currency Translation The Company’s functional currency is US dollars. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into US dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in income. The Company’s integrated foreign subsidiaries are financially or operationally dependent on the Company. The Company uses the temporal method to translate the accounts of its integrated operations into US dollars. Monetary assets and liabilities are translated at the exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are translated at historical rates. Revenues and expenses are translated at average rates for the period, except for amortization, which is translated on the same basis as the related asset. The resulting exchange gains or losses are recognized in income.
Recent Accounting Pronouncements	(d) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Equipment (Tables)

Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Equipment is amortized over its useful life. Schedule of Property and Equipment Cost Depreciation Net Computer 3 years $ 1,500 $ 208 $ 1,292

Share Based Payments (Tables)

Share Based Payments (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	Stock option transactions are summarized as follows: Summary of Stock Option Activity Number of Weighted Average Options Exercise Price Balance, December 31, 2021 - $ - Granted 8,500,000 0.10 Exercised - - Cancelled/Expired - - Balance, September 30, 2022 8,500,000 $ 0.10 Exercisable at September 30, 2022 7,700,000 $ 0.10

Correction of Previously Issu_2

Correction of Previously Issued Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Schedule of Stockholders’ Deficit	Consolidated Statement of Stockholders’ Deficit Schedule of Stockholders’ Deficit Common stock Deficit Total $ $ $ Balance, December 31, 2020, as previously stated 40,025 (9,781,190 ) (3,408,331 ) Adjustment (40,025 ) 40,025 – Balance, December 31, 2020, as restated – (9,741,165 ) (3,408,331 )

Nature of Operations and Cont_2

Nature of Operations and Continuance of Business (Details Narrative) - USD ($)	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficiency	$ 1,066,438
Liability of principal stockholders	1,030,496
Accumulated deficit	$ 11,229,862	$ 10,003,209	$ 9,741,165

Investment in and Due to Rela_2

Investment in and Due to Related Company (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Due to related parties	$ 12,606		$ 12,606		$ 33,964
Revenue		$ 790		$ 150,790
AQUAtap [Member]
Equity method investment, ownership percentage							38%
AQUAtap [Member]
Investments							$ 7,600
Gain loss on investment			$ 0		0	$ 0
Due to related parties					33,964	183,964
Prepayment from purchaser						$ 150,000
Revenue					$ 150,000

Schedule of Property and Equipm

Schedule of Property and Equipment (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Equipment, cost	$ 1,500
Equipment, depreciation	208
Equipment, net	$ 1,292
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Equipment, Useful Life	3 years

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended
	Jul. 22, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Due to related parties		$ 1,030,496		$ 1,030,496		$ 3,632,758
Management fee		112,500	$ 107,500	337,500	$ 322,500
Shares issued, price per share	$ 0.065
President [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Due to related parties		431,638		431,638		1,703,755
Vice President [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Due to related parties		$ 598,858		598,858		$ 1,929,003
Payment of rent				15,750	15,750
Issuance of shares during period	46,738,460
Issuance of value during period	$ 3,038,000
President and Vice President [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Management fee				$ 337,500	$ 322,500

Common Stock (Details Narrative

Common Stock (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended
	Jul. 22, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jul. 21, 2022	Jul. 20, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Authorized share of common stock		500,000,000		500,000,000		500,000,000	95,000,000	500,000,000
Common stock, par value		$ 0.000001		$ 0.000001		$ 0.000001		$ 0.000001
Shares issued, price per share	$ 0.065
Common stock, shares outstanding		131,903,029		131,903,029				131,903,029
Net income (loss) available to common stockholders, basic				$ 454,684	$ 331,198
Weighted average number of shares outstanding, basic		120,726,441	85,164,569	97,148,790	85,164,569
Stock option, shares				8,500,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares outstanding		131,903,029		131,903,029				85,164,569
Vice President [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Converted of aggregated debt, value	$ 3,038,000
Issuance of shares during period	46,738,460

Summary of Stock Option Activit

Summary of Stock Option Activity (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Share-Based Payment Arrangement [Abstract]
Number of options outstanding, beginning balance | shares
Weighted average exercise price, beginning | $ / shares
Number of options outstanding, granted | shares	8,500,000
Weighted average exercise price, granted | $ / shares	$ 0.10
Number of options outstanding, exercised | shares
Weighted average exercise price, exercised | $ / shares
Number of options outstanding, cancelled/expired | shares
Weighted average exercise price, cancelled/expired | $ / shares
Number of options outstanding, ending balance | shares	8,500,000
Weighted average exercise price, Ending | $ / shares	$ 0.10
Number of options exercisable | shares	7,700,000
Weighted average exercise price, exercisable | $ / shares	$ 0.10

Share Based Payments (Details N

Share Based Payments (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-Based Payment Arrangement [Abstract]
Issued and outstanding common stock percentage			10%
Option granted maximum term years			10 years
Exercise price	$ 0.10		$ 0.10
Remaining life			4 years 9 months 14 days
Options, shares	800,000		800,000
Stock based payment expense	$ 801,102		$ 801,102

Schedule of Stockholders_ Defic

Schedule of Stockholders’ Deficit (Details) - USD ($)	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock issuable
Deficit	$ (11,229,862)			$ (10,003,209)				(9,741,165)
Total Stockholder's Deficit	$ (1,057,926)	$ (3,957,731)	$ (3,815,010)	$ (3,670,375)	$ (3,739,529)	$ (3,608,238)	$ (3,490,884)	(3,408,331)
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock issuable								40,025
Deficit								(9,781,190)
Total Stockholder's Deficit								(3,408,331)
Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock issuable								(40,025)
Deficit								40,025
Total Stockholder's Deficit

Correction of Previously Issu_3

Correction of Previously Issued Financial Statements (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2014
Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Adjustment to equity	$ 40,025
Consulting and Marketing Agreements [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Common stock shares issued		500,000
Common stock value issued		$ 40,025